• 
  Aurélie Jourdes, Elise Cellerin, Cyrille Touzeau, Stéphanie Harel, Blandine Denis, et al.. Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study. Clinical Microbiology and Infection, 2024, 30 (6), pp.764-771. ⟨10.1016/j.cmi.2024.02.023⟩. ⟨hal-04916309⟩
• 
  Sandrine Hayette, Béatrice Grange, Maxime Vallee, Claire Bardel, Sarah Huet, et al.. Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies. HemaSphere, 2021, 5 (2), pp.e522. ⟨10.1097/HS9.0000000000000522⟩. ⟨hal-04382990⟩
• 
  Radu Chiriac, Luc‐marie Gerland, Lucile Baseggio. Neoplastic plasma cells with concomitant azurophilic crystalline inclusions and Snapper‐Schneid bodies. eJHaem, 2024, 5 (5), pp.1076-1077. ⟨10.1002/jha2.1004⟩. ⟨hal-04911072⟩
• 
  Guillaume P Andrieu, Guillaume Hypolite, Mehdi Latiri, Estelle Balducci, Caroline Costa, et al.. ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.. Blood Advances, 2024, ⟨10.1182/bloodadvances.2024013762/2313924/bloodadvances.2024013762.pdfbygueston⟩. ⟨hal-04910700⟩
• 
  Simon Menez, Estelle Bourbon, Romain Gounot, Jean-Jacques Tudesq, Niels Moya, et al.. CAR T-cells in very elderly (≥80 years) lymphoma patients: a DESCAR-T analysis. Leukemia and Lymphoma/leukemia and Lymphoma, 2024, 65 (13), pp.2048-2051. ⟨10.1080/10428194.2024.2387731⟩. ⟨hal-04900613⟩
• 
  Cédric Rossi, Guillaume Manson, Amira Marouf, Aurélie Cabannes-Hamy, Emmanuelle Nicolas-Virelizier, et al.. Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines. European Journal of Cancer, 2024, European Journal of Cancer, 213, pp.115073. ⟨10.1016/j.ejca.2024.115073⟩. ⟨hal-04851826⟩
• 
  Eric Durot, Damien Roos-Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, et al.. High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia. Blood, 2024, 143 (26), pp.2804-2807. ⟨10.1182/blood.2024024452⟩. ⟨hal-04811236⟩
• 
  C. Bommier, Marie Donzel, C. Rossi, L. Fornecker, F. Bijou, et al.. Real‐world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study. Hematological Oncology, 2024, 42 (6), pp.e3314. ⟨10.1002/hon.3314⟩. ⟨hal-04753006⟩
• 
  Juan Pablo Cerapio, Pauline Gravelle, Anne Quillet‐mary, Carine Valle, Frederic Martins, et al.. Integrated spatial and multimodal single‐cell transcriptomics reveal patient‐dependent cell heterogeneity in splenic marginal zone lymphoma. Journal of Pathology, 2024, 263 (4-5), pp.442 - 453. ⟨10.1002/path.6296⟩. ⟨inserm-04773413⟩
• 
  Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, et al.. Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients. Journal of Hematology and Oncology, 2024, 17 (1), pp.86. ⟨10.1186/s13045-024-01606-w⟩. ⟨hal-04719756⟩
• 
  P. Sesques, A. A. Kirkwood, M. Kwon, K. Rejeski, M. D. Jain, et al.. Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma.. Journal of Hematology and Oncology, 2024, Journal of Hematology and Oncology, 17, pp.61. ⟨10.1186/s13045-024-01579-w⟩. ⟨hal-04700899⟩
• 
  Camille Libre, Ludovic Moro-Sibilot, Stéphane Giraud, Laetitia Martin, Els Verhoeyen, et al.. Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant. Cancers, 2020, 12 (4), pp.901. ⟨10.3390/cancers12040901⟩. ⟨hal-04654379⟩
• 
  Gilles Crochet, Gloria Iacoboni, Audrey Couturier, Emmanuel Bachy, Josu Iraola-Truchuelo, et al.. Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.. Blood, 2024, ⟨10.1182/blood.2024024526⟩. ⟨hal-04607118⟩
• 
  Shaoying Wang, Margaux Prieux, Simon de Bernard, Maxence Dubois, Daphne Laubreton, et al.. Exogenous IL-2 delays memory precursors generation and is essential for enhancing memory cells effector functions. iScience, 2024, 27 (4), pp.109411. ⟨10.1016/j.isci.2024.109411⟩. ⟨hal-04598215⟩
• 
  Alaa Al Assi, Solène Posty, Frédéric Lamarche, Amel Chebel, Jérôme Guitton, et al.. A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity. Cell Death and Disease, 2024, 15 (5), pp.311. ⟨10.1038/s41419-024-06668-9⟩. ⟨hal-04566195⟩

30

112